CYP24A1 and non-small cell lung carcinoma: Along the same lines, a study carried out in 146 Caucasian patients (from Spain) diagnosed with NSCLC associated the CYP24A1 rs6068816-TT genotype with lower survival (p = 0.005, HR = 3.75, 95% CI = 1.49–9.41; TT vs. C) and greater progression of the disease in non-resected patients (p = 0.018, HR = 2.99, 95% CI = 1.21–7.45; TT vs. C) [25].